SEC 13F Intelligence

Apeiron Ria LLC / ABT

Apeiron Ria LLC’s Abbott Laboratories Position

Does Apeiron Ria LLC own Abbott Laboratories (ABT)? Not currently — the last reported position was 80.6K shares worth $9M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q1 2024
Shares
80.6K
% of Portfolio
+2.65%
Quarters Held
10
position exited

Position History ABT

Reported value by quarter
Q4 ’21: $12MQ4 ’21Q1 ’22: $11MQ2 ’22: $94MQ2 ’22Q3 ’22: $8MQ4 ’22: $10MQ4 ’22Q1 ’23: $9MQ2 ’23: $9MQ2 ’23Q3 ’23: $8MQ4 ’23: $10MQ4 ’23Q1 ’24: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202480.6K$9M+2.65%
Q4 202386.7K$10M+2.98%
Q3 202386.7K$8M+2.86%
Q2 202386.7K$9M+3.24%
Q1 202386.7K$9M+3.11%
Q4 202288.5K$10M+3.72%
Q3 202286.7K$8M+3.86%
Q2 202288.6K$94M+26.32%
Q1 202288.5K$11M+5.21%
Q4 202188.5K$12M+5.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Apeiron Ria LLC’s full portfolio or all institutional holders of ABT.